Calgary, Alberta – An innovative pharmaceutical researcher has joined Syantra Inc. as Senior Scientist, Molecular Discovery. Olesya Kharenko, Ph.D. has extensive experience in molecular biology, epigenetics, chemical biology and target validation in breast cancer and other areas.
“Olesya Kharenko focuses not only on the molecular nature of human disease, but importantly on the dynamic context in which it exists. Her 15 years of professional experience working in biotechnology and pharmaceuticals bring exactly the skill set Syantra was looking for. We are excited for the contributions we know Olesya will make to the company, and welcome her to the team,” said Robert Shepherd, the company’s Chief Executive Officer.
Prior to joining Syantra, Dr. Kharenko spent over 10 leading oncology and discovery teams at Resverlogix and Zenith Epigenetics focused on addressing resistance to current therapies, as well as target validation and pre-clinical development of small molecule drugs and compounds.
She has co-authored over 35 peer-reviewed publications, is an inventor on several patents and has widely presented at international meetings.
“Dr. Kharenko has a great breadth of scientific expertise as well as demonstrated leadership in bringing molecular discoveries through to product development and clinical studies,” said Kristina Rinker, the company’s Chief Scientific Officer.
Dr. Kharenko earned her Ph.D. degree in bio-inorganic chemistry in 2005 from the Bowling Green State University, OH, USA. She also holds Master’s and Bachelor’s degrees in Chemistry.
An avid hiker and outdoor enthusiast, she can be found in the beautiful Canadian Rockies when not at work. She is a volunteer organizer in the Calgary hiking club.
-30-
About Syantra Inc.
Syantra Inc. is a precision healthcare company that’s changing the way cancer is detected and treated. Its flagship product, Syantra DX Breast Cancer, is a blood test for breast cancer detection that utilizes a proprietary suite of biomarkers and software to provide a positive or negative result.
Contact
Visit syantra.com to learn more about Syantra or to get a test.
Carol Roesler, Senior Director, Business Development & People
2023 | Syantra Inc. | 1-877-331-0516
We value your privacy.
Read about it here
Website and branding by:
IVY Design Inc.
We